Experts are increasingly focused on “quiet progression” in MS — the gradual worsening of symptoms even when no new relapses or MRI lesions appear. In a recent interview, MS specialist Dr. Regina Berkovich explained that while treatments have become very effective at controlling inflammation and preventing relapses, addressing this silent progression remains a major challenge. She highlighted promising research into new therapies targeting different mechanisms, though drug development is slow and unpredictable. Dr. Berkovich also emphasized that lifestyle choices — including daily movement, healthier eating, stress reduction, and avoiding smoking — can meaningfully influence long-term function. She encourages patients to work with experienced, open-minded neurologists and to preserve their current abilities while awaiting future advancements in MS treatment.
